Skip to content
LexBuild

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction

---
identifier: "/us/fr/2023-08279"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2023-08279"
section_name: "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction"
positive_law: false
currency: "2023-04-19"
last_updated: "2023-04-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-08279"
document_type: "notice"
publication_date: "2023-04-19"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "88 FR 24191"
fr_volume: 88
docket_ids:
  - "Docket No. FDA-2023-N-1338"
fr_action: "Notice; establishment of a public docket; request for comments; correction."
---

#  Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; establishment of a public docket; request for comments; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the *Federal Register* of April 11, 2023. The document announced a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy, Planning, Legislation and International Affairs, Food and Drug Administration, 301-796-9115, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Tuesday, April 11, 2023 (88 FR 21688) in FR Doc. 2023-248, the following corrections are made:

1. On page 21688, in the third column, in the header of the document, “Docket No. FDA-2023-N-0378” is corrected to read “Docket No. FDA-2023-N-1338” and in the *ADDRESSES* section, in the third line of the last paragraph, “FDA-2023-N-0378” is corrected to read “FDA-2023-N-1338.”

2. On page 21689, in the first column, in the second line of the “Instructions:” section, Docket No. FDA-2023-N-0378” is corrected to read “Docket No. FDA-2023-N-1338”.

Dated: April 14, 2023.

Lauren K. Roth,

Associate Commissioner for Policy.